## Case-Control vs Cohort: The Selection Principle **Key Point:** The critical distinguishing feature of a case-control study is that participants are **selected based on their disease status** (presence or absence of the outcome), not their exposure status. This is the reverse of how cohort studies enroll participants. ### Study Design Architecture ```mermaid flowchart TD A[Research Question: OCP → VTE?]:::outcome --> B{Which design?}:::decision B -->|Cohort approach| C[Enroll by exposure status]:::action C --> D[OCP users vs non-users]:::action D --> E[Follow forward in time]:::action E --> F[Measure VTE incidence]:::action F --> G[Calculate Relative Risk]:::outcome B -->|Case-Control approach| H[Enroll by disease status]:::action H --> I[VTE cases vs controls]:::action I --> J[Look back at OCP use]:::action J --> K[Measure exposure prevalence]:::action K --> L[Calculate Odds Ratio]:::outcome ``` ### Why This Vignette is Case-Control 1. **Selection criterion:** Women are enrolled **because they have (or don't have) VTE** — this is the defining characteristic 2. **Temporal direction:** History is obtained **retrospectively** after disease has already occurred 3. **Exposure assessment:** OCP use is determined **after** disease status is known 4. **Measure of association:** Odds ratio is calculated (not relative risk) ### Comparison: What Each Study Type Measures | Aspect | Cohort Study | Case-Control Study | |--------|--------------|--------------------| | **Selection starts with** | Exposure status | Disease status | | **Enrollment question** | "Are you exposed?" | "Do you have the disease?" | | **Time direction** | Forward (prospective or retrospective follow-up) | Backward (retrospective exposure assessment) | | **Incidence/Prevalence** | Measures incidence directly | Measures exposure prevalence | | **Measure of effect** | Relative Risk (RR) | Odds Ratio (OR) | | **Best for** | Common diseases, long latency | Rare diseases, quick answers | **High-Yield:** In the vignette, the phrase "enrolls 500 women **with** VTE and 500 women **without** VTE" is the smoking gun. This is selection by disease outcome — the hallmark of case-control design. **Clinical Pearl:** Case-control studies are ideal for rare outcomes like VTE (which affects ~1-2 per 1000 person-years). A cohort study would require enrolling thousands of women and following them for years to observe enough VTE cases. A case-control study efficiently compares OCP exposure between women who already have VTE and matched controls. **Warning:** Do not confuse "retrospective" with "case-control." A cohort study can also be retrospective (using historical medical records). The defining feature is **selection by exposure status** (cohort) vs. **selection by disease status** (case-control).
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.